Which has grown faster, ABUS or SIBN?

Over the past five years, ABUS grew revenue faster — ABUS at a 85.17% CAGR versus SIBN at 20.20%.

Is ABUS or SIBN more profitable?

ABUS runs the higher net margin — ABUS at 84.23% versus SIBN at -6.85%.

How have ABUS and SIBN total returns compared?

Over the past 5 years, ABUS delivered 2.19% and SIBN delivered -1.46% annualized total return. Past performance doesn't predict future results.

Arbutus Biopharma Corp (ABUS) vs SI-BONE, Inc. (SIBN)

A side-by-side comparison of Arbutus Biopharma Corp and SI-BONE, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABUS

Arbutus Biopharma Corp

$885M

$4.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SIBN

SI-BONE, Inc.

$866M

$19.53HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT

Total return — ABUS vs SIBN

growth of $100 · dividends reinvested · last 8y

ABUS +8.4% (+1.0%/yr)SIBN -1.2% (-0.2%/yr)ABUS compounded faster over this window

ABUS SIBN

ABUS vs SIBN: by the numbers

•ABUS is the larger company ($885M vs $866M market cap).
•ABUS is profitable (84.23% net margin) while SIBN runs a net loss (-6.85%).
•ABUS grew revenue faster over the past five years (85.17% vs 20.20% CAGR).

Metrics side by side

Valuation

Metric	ABUS	SIBN
P/E ratio	5.74	N/A
Forward P/E	6.05	N/A
P/S ratio	4.87	4.05
P/B ratio	3.42	4.75
EV / EBITDA	5.90	N/A

Profitability

Metric	ABUS	SIBN
Gross margin	99.98%	79.53%
Operating margin	-192.08%	-8.31%
Net margin	84.23%	-6.85%
ROE	59.16%	-8.03%
ROIC	54.39%	-7.88%

Growth (annualized)

Metric	ABUS	SIBN
Revenue CAGR (5Y)	85.17%	20.20%
Total return CAGR (5Y)	2.19%	-1.46%

Frequently asked

Which has grown faster, ABUS or SIBN?: Over the past five years, ABUS grew revenue faster — ABUS at a 85.17% CAGR versus SIBN at 20.20%.
Is ABUS or SIBN more profitable?: ABUS runs the higher net margin — ABUS at 84.23% versus SIBN at -6.85%.
How have ABUS and SIBN total returns compared?: Over the past 5 years, ABUS delivered 2.19% and SIBN delivered -1.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABUS analysis Full SIBN analysis Interactive comparison tool

Dig into the metrics

Arbutus Biopharma P/E ratio Arbutus Biopharma ROE SI-BONE ROE Arbutus Biopharma operating margin SI-BONE operating margin Arbutus Biopharma revenue growth SI-BONE revenue growth Arbutus Biopharma free cash flow SI-BONE free cash flow

Arbutus Biopharma & SI-BONE appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.